| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/04/2002 | CA2331934A1 Protein and its encoding nucleotide sequences for diagnosis, prevention and treatment of lung injuries and disorders |
| 06/04/2002 | CA2237805C Nucleic acid molecule encoding a 11-cis retinol dehydrogenase |
| 06/04/2002 | CA2171424C Acylated insulin |
| 06/04/2002 | CA2084384C Dna coding for uricase and process for producing uricase |
| 06/04/2002 | CA2011450C Recombinant b-chain of the il-2 receptor |
| 06/04/2002 | CA1341364C Single polypeptide chain binding molecules |
| 06/01/2002 | CA2325666A1 Immunogenic mutated peptides derived from r9m, polynucleotides, coding polynucleotides and their therapeutic uses |
| 06/01/2002 | CA2325088A1 Novel membrane fusion proteins derived from poikilothermic reovirus |
| 05/30/2002 | WO2002042776A2 Compositions and methods relating to prostate specific genes and proteins |
| 05/30/2002 | WO2002042772A1 TRIPEPTIDE OF FCηRIIA |
| 05/30/2002 | WO2002042767A2 Step-wise process to recover or eliminate biological substances by flotation from underlayered colloidal medium |
| 05/30/2002 | WO2002042733A2 Method for analyzing mass spectra |
| 05/30/2002 | WO2002042499A2 Compositions and methods relating to prostate specific genes and proteins |
| 05/30/2002 | WO2002042497A2 Methods using fluorescens energy transfer probes for detecting cleavage of nucleic acids |
| 05/30/2002 | WO2002042494A1 Method of quantifying hiv-1 rna-dna hybrid and diagnosis kit |
| 05/30/2002 | WO2002042492A2 Method for detecting protozoae of the genus naegleria |
| 05/30/2002 | WO2002042491A2 Method for identifying compounds or lead structures against rna target motifs and rna/protein interactions |
| 05/30/2002 | WO2002042487A2 Compositions, methods and kits relating to remodelin |
| 05/30/2002 | WO2002042482A2 Functional lentiviral vector from an mlv-based backbone |
| 05/30/2002 | WO2002042481A1 Paramyxovirus vector encoding angiogenesis gene and utilization thereof |
| 05/30/2002 | WO2002042480A2 Modified vaccinia ankara virus variant |
| 05/30/2002 | WO2002042479A2 Polynucleotides encoding defense response proteins |
| 05/30/2002 | WO2002042478A2 Nematode resistant plant |
| 05/30/2002 | WO2002042477A2 Process for increasing the level of sterols in plants |
| 05/30/2002 | WO2002042476A1 System for expressing proteins in the rhizosphere of plants and method for building said system |
| 05/30/2002 | WO2002042474A1 Zygomycetes-origin endoglucanase lacking cellulose-binding domain |
| 05/30/2002 | WO2002042473A1 Bacterial gene encoding a phenylurea hydrolase |
| 05/30/2002 | WO2002042472A1 Nucleotide sequences which code for the mtra and mtrb gene |
| 05/30/2002 | WO2002042471A2 Methods and materials for the synthesis of organic products |
| 05/30/2002 | WO2002042470A1 Isolated luciferases and the use thereof |
| 05/30/2002 | WO2002042469A1 Isolated luciferases lu164, lual and lu22, and the use of the same |
| 05/30/2002 | WO2002042467A2 Aspergillus fumigatus profilin |
| 05/30/2002 | WO2002042466A2 Nucleotide sequences coding for the cysq gene |
| 05/30/2002 | WO2002042465A1 Production of stilbenes in transgenic plants and the method of producing thereof |
| 05/30/2002 | WO2002042464A2 Human v2 vomeronasal receptor |
| 05/30/2002 | WO2002042463A2 Compositions and methods relating to prostate specific genes and proteins |
| 05/30/2002 | WO2002042462A2 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
| 05/30/2002 | WO2002042461A2 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 05/30/2002 | WO2002042460A2 Compositions and methods relating to colon specific genes and proteins |
| 05/30/2002 | WO2002042459A2 Position dependent recognition of gnn nucleotide triplets by zinc fingers |
| 05/30/2002 | WO2002042458A2 G protein coupled receptors |
| 05/30/2002 | WO2002042457A1 Cloning and expression of human slap-2: a novel sh2/sh3 domain-containing human slap homologue having immune cell-specific expression |
| 05/30/2002 | WO2002042456A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 05/30/2002 | WO2002042455A2 Modifier of organelle metalbolism |
| 05/30/2002 | WO2002042454A2 Gene involved in schizophrenia |
| 05/30/2002 | WO2002042453A1 A novel polypeptide, a human big protein 0767-19.36 and the polynucleotide encoding the polypeptide |
| 05/30/2002 | WO2002042452A2 Adapter protein and gene encoding it |
| 05/30/2002 | WO2002042451A2 Aspergillus fumigatus cofilin |
| 05/30/2002 | WO2002042450A1 Sugarcane bacilliform virus promoters derived from isolates isolated from sugarcane cultivars |
| 05/30/2002 | WO2002042449A2 Method for selecting peptide ligands |
| 05/30/2002 | WO2002042447A2 Surface transfection and expression procedure |
| 05/30/2002 | WO2002042446A1 Prgr: a positive selection vector system for direct cloning of pcr amplified dna fragments |
| 05/30/2002 | WO2002042445A2 Differentiated cells suitable for human therapy |
| 05/30/2002 | WO2002042444A2 Fungal gene cluster associated with pathogenesis |
| 05/30/2002 | WO2002042441A2 VON WILLEBRAND FACTOR (vWF) CLEAVING PROTEASE POLYPEPTIDE, NUCLEIC ACID ENCODING THE POLYPEPTIDE AND USE OF POLYPEPTIDE |
| 05/30/2002 | WO2002042440A2 Regulation of plant growth by modifying the expression of a putative trna-isope ntenyl transferase |
| 05/30/2002 | WO2002042437A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 05/30/2002 | WO2002042436A2 Isolated human phosphatase proteins, nucleic acid molecules encoding them, and uses thereof |
| 05/30/2002 | WO2002042435A2 Regulation of human tyrosine phosphatase |
| 05/30/2002 | WO2002042434A1 Cells to be used in producing virus vector, process for producing the same and process for producing virus vector with the use of the cells |
| 05/30/2002 | WO2002042430A1 Nucleic acid extraction device |
| 05/30/2002 | WO2002042425A2 Antisense modulation of mp-1 expression |
| 05/30/2002 | WO2002042424A2 Seed-preferred regulatory elements and uses thereof |
| 05/30/2002 | WO2002042423A2 Antisense modulation of src-2 expression |
| 05/30/2002 | WO2002042419A2 Cell culture apparatus and methods of use |
| 05/30/2002 | WO2002042418A2 3-hydroxypropionic acid and other organic compounds |
| 05/30/2002 | WO2002042417A2 Human erg2 potassium channel |
| 05/30/2002 | WO2002042336A2 Fgf-affinity chromatography |
| 05/30/2002 | WO2002042333A1 Anti-cd14 monoclonal antibody having effect of inhibiting cd14/tlr binding |
| 05/30/2002 | WO2002042332A2 Truncated cd200 |
| 05/30/2002 | WO2002042330A2 Cystoskeleton-associated proteins |
| 05/30/2002 | WO2002042328A2 Method for studying the effects of commensal microflora on mammalian intestine and treatments of gastrointestinal-associated disease based thereon |
| 05/30/2002 | WO2002042327A2 Cocoa albumin and its use in the production of cocoa and chocolate flavour |
| 05/30/2002 | WO2002042326A1 A method of expression and agents identified thereby |
| 05/30/2002 | WO2002042325A2 Cyp1b1 nucleic acids and methods of use |
| 05/30/2002 | WO2002042324A1 Gene encoding protein cluster i and the encoded protein |
| 05/30/2002 | WO2002042317A2 Method of separating extra-chromosomal dna from other cellular components |
| 05/30/2002 | WO2002042316A2 Pna analogues |
| 05/30/2002 | WO2002042118A2 Oil maintenance indicator |
| 05/30/2002 | WO2002041922A1 Method of regulating the activity of expression product of gene transferred into living body |
| 05/30/2002 | WO2002041888A1 Anticancer agent comprising mycolactone |
| 05/30/2002 | WO2002041843A2 Antiinflammation agents |
| 05/30/2002 | WO2002041839A2 Assays for inhibitors of neuronal transport of alzheimer's amyloid precursor protein |
| 05/30/2002 | WO2002041836A2 Antisense modulation of src-1 expression |
| 05/30/2002 | WO2002041833A2 Carotenoid biosynthesis |
| 05/30/2002 | WO2002041691A2 Transgenic or recombinant non-human mammals and their uses in screening psycho-active medicines |
| 05/30/2002 | WO2002028423A8 Stabilisation of plasmid inheritance in bacteria by preventing multimerisation |
| 05/30/2002 | WO2002024864A3 Antisense modulation of syntaxin 4 interacting protein expression |
| 05/30/2002 | WO2002022782A3 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 05/30/2002 | WO2002022679A3 Variants of phleum pratense allergenic proteins |
| 05/30/2002 | WO2002022648A3 Compositions and methods for inducing specific cytolytic t cell responses |
| 05/30/2002 | WO2002022633A3 Nucleotide sequences which code for the atr61 gene |
| 05/30/2002 | WO2002020799A3 Nucleotide sequences which code for the luxs gene |
| 05/30/2002 | WO2002020736A9 Proteases |
| 05/30/2002 | WO2002018581A9 G-protein coupled receptors |
| 05/30/2002 | WO2002018438A9 Modified proteins, isolated novel peptides, and uses thereof |
| 05/30/2002 | WO2002016579A8 Nucleic acids, vectors, host cells, polypeptides and uses thereof |
| 05/30/2002 | WO2002014496A3 G protein-coupled receptors |
| 05/30/2002 | WO2002012548A8 METHOD OF ANALYZING NFλB ACTIVITY |
| 05/30/2002 | WO2002012437A3 Production of humanized antibodies in transgenic animals |